Get started
Author

Jiseon Yoo

Observed institution: ABL Bio (South Korea)
ORCID: 0000-0002-6024-8089
Observed ORCID: 0000-0002-6024-8089
OpenAlex ID: A5012029585
Enhanced cell growth, production, and mAb quality produced in Chinese hamster ovary-K1 cells by supplementing polyamine in the media
2023 · Da Eun Kang, Yeong Bin An, et al. · Applied Microbiology and Biotechnology · 17
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release
2023 · Eunhee Lee, Shinai Lee, et al. · Journal for ImmunoTherapy of Cancer · 16
PDF
Genome-Wide CRISPR/Cas9 Screening Unveils a Novel Target ATF7IP–SETDB1 Complex for Enhancing Difficult-to-Express Protein Production
2024 · Su Hyun Kim, Jong-Ho Park, et al. · ACS Synthetic Biology · 14
Abstract 4246: ABL103, A novel T-cell engaging bispecific antibody, exhibits potent in vitro and vivo antitumor activity and low toxicity via B7-H4 dependent 4-1BB activation in tumor microenvironment
2022 · Kyungjin Park, Yangsoon Lee, et al. · Cancer Research · 3
Cell line-specific impact of dexamethasone on the bioprocessing of Chinese hamster ovary cells
2024 · Yeong Bin An, Da Eun Kang, et al. · Biotechnology and Bioprocess Engineering · 1
Preclinical development of ABL206, a novel bispecific antibody-drug conjugate targeting B7-H3 and ROR1
2026 · Jung A. Kwon, Suyoun Lee, et al. · mAbs
PDF
Abstract 5811: ABL103, a bispecific antibody targeting B7-H4 and 4-1BB, shows synergistic immune responses with combination of pembrolizumab in the immunosuppressive tumor microenvironment
2025 · Chorong Yang, Eunhee Lee, et al. · Cancer Research
Abstract 2941: ROR1 targeted 4-1BB costimulatory bispecific antibody, ABL102, exhibits potent in vitro and vivo antitumor activity and superior safety profile
2023 · Yangsoon Lee, Kyeong-Su Park, et al. · Cancer Research
Works count: 8
Citation count: 51
H-index: 3
I10-index: 3
Year
Topic
Type